Login / Signup

Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data.

Andrei BarbulescuJohan AsklingKaterina ChatzidionysiouHelena Forsblad-d'EliaAlf KastbomUlf LindströmCarl TuressonThomas Frisell
Published in: Rheumatology (Oxford, England) (2022)
Baricitinib and tofacitinib showed at least equivalent effectiveness compared with bDMARDs after exploring several different effectiveness measures.
Keyphrases
  • rheumatoid arthritis
  • randomized controlled trial
  • systematic review
  • ulcerative colitis
  • electronic health record
  • cross sectional
  • machine learning
  • ankylosing spondylitis
  • deep learning